| 11028077 |
Crystalline pharmaceutical and methods of preparation and use thereof |
Thomas Gadek, Frederic Naud |
2021-06-08 |
$23,526,000 |
| 10960087 |
Compositions and methods for treatment of diabetic retinopathy |
Thomas Gadek, Charles Semba |
2021-03-30 |
$110,497,000 |
| 10188641 |
Compositions and methods for treatment |
Thomas Gadek |
2019-01-29 |
|
| 9890141 |
Crystalline pharmaceutical and methods of preparation and use thereof |
— |
2018-02-13 |
|
| 9447077 |
Crystalline pharmaceutical and methods of preparation and use thereof |
Thomas Gadek, Frederic Naud |
2016-09-20 |
|
| 9353088 |
Crystalline pharmaceutical and methods of preparation and use thereof |
— |
2016-05-31 |
|
| 9045457 |
Compositions and methods for treatment |
Thomas Gadek, Min Zhong, Wang Shen, Johan D. Oslob, Kenneth J. Barr |
2015-06-02 |
|
| 8927574 |
Crystalline pharmaceutical and methods of preparation and use thereof |
— |
2015-01-06 |
|
| 8871935 |
Crystalline pharmaceutical and methods of preparation and use thereof |
Thomas Gadek, Frederic Naud |
2014-10-28 |
|
| 8592450 |
Compositions and methods for treatment of eye disorders |
Thomas Gadek |
2013-11-26 |
|
| 8378105 |
Crystalline pharmaceutical and methods of preparation and use thereof |
— |
2013-02-19 |
|
| 8367701 |
Crystalline pharmaceutical and methods of preparation and use thereof |
Thomas Gadek, Frederic Naud |
2013-02-05 |
|
| 8168655 |
Compositions and methods for treatment of eye disorders |
Thomas Gadek |
2012-05-01 |
|
| 8143447 |
Treatment of cancer |
Jerome Moore, Bruce Keyt, Barry M. Sherman, Max Totrov, Valeria Ossovskaya |
2012-03-27 |
|
| 8080562 |
Crystalline pharmaceutical and methods of preparation and use thereof |
Thomas Gadek, Frederic Naud |
2011-12-20 |
|
| 7538252 |
Drug design for tubulin inhibitors, compositions, and methods of treatment thereof |
Valeria Ossovskaya, Barry M. Sherman, Max Totrov |
2009-05-26 |
|
| 7094869 |
Low molecular weight peptidomimetic growth hormone secretagogues |
Todd C. Somers, Kathleen Ann Elias, Ross G. Clark, Robert McDowell, Mark S. Stanley +1 more |
2006-08-22 |
$234,810,000 |
| 6525022 |
Receptor specific atrial natriuretic peptides |
David G. Lowe, Brian C. Cunningham, David A. Oare, Robert McDowell |
2003-02-25 |
$187,752,000 |
| 6034216 |
Low molecular weight peptidomimetic growth hormone secretagogues |
Todd C. Somers, Kathleen Ann Elias, Ross G. Clark, Robert McDowell, Mark S. Stanley +1 more |
2000-03-07 |
$194,809,000 |
| 5846932 |
Receptor specific atrial natriuretic peptides |
David G. Lowe, Brian C. Cunningham, David A. Oare, Robert McDowell |
1998-12-08 |
$9,313,000 |
| 5798337 |
Low molecular weight peptidomimetic growth hormone secretagogues |
Todd C. Somers, Kathleen Ann Elias, Ross G. Clark, Robert McDowell, Mark S. Stanley +1 more |
1998-08-25 |
$7,448,000 |
| 5763256 |
Serine protease variants having peptide ligase activity |
Lars Abrahmsen, James A. Wells |
1998-06-09 |
$1,826,000 |
| 5756452 |
Platelet aggregation inhibitors having high specificity for GP II.sub.b III.sub.a |
Thomas Gadek, Robert McDowell |
1998-05-26 |
$3,135,000 |
| 5736512 |
Serine protease variants having peptide ligase activity |
Lars Abrahmsen, James A. Wells, David T. Jackson |
1998-04-07 |
$2,247,000 |
| 5665704 |
Receptor specific atrial natriuretic peptides |
David G. Lowe, Brian C. Cunningham, David A. Oare, Robert McDowell |
1997-09-09 |
$4,300,000 |
